Vivanza Biosciences Limited (VIVANZA.BO)
INR 3.5
(-3.58%)
INR 3.5
(-3.58%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 14.83 Million INR | 114.27% |
| 2022 | 6.92 Million INR | 1000.48% |
| 2021 | 629 Thousand INR | -36.07% |
| 2020 | 983.9 Thousand INR | 129.48% |
| 2019 | -3.33 Million INR | -1580.69% |
| 2018 | -198.55 Thousand INR | -103.3% |
| 2017 | 6.02 Million INR | 299.06% |
| 2016 | -3.02 Million INR | -397.9% |
| 2015 | -607.76 Thousand INR | -15.68% |
| 2014 | -525.36 Thousand INR | -3.14% |
| 2013 | -509.34 Thousand INR | 5.27% |
| 2012 | -537.68 Thousand INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 1.05 Million INR | -77.46% |
| 2024 Q1 | 4.66 Million INR | 421.81% |
| 2023 Q4 | -1.44 Million INR | -149.9% |
| 2023 Q2 | 3.17 Million INR | -46.17% |
| 2023 Q3 | 2.9 Million INR | -8.65% |
| 2023 FY | 10.6 Million INR | 53.13% |
| 2023 Q1 | 5.9 Million INR | 13224.44% |
| 2022 Q4 | -45 Thousand INR | -100.8% |
| 2022 Q2 | 2.71 Million INR | 117.99% |
| 2022 FY | 6.92 Million INR | 1000.48% |
| 2022 Q1 | 1.24 Million INR | 211.66% |
| 2022 Q3 | 5.59 Million INR | 106.08% |
| 2021 Q4 | -1.11 Million INR | -472.91% |
| 2021 Q1 | -460 Thousand INR | 42.21% |
| 2021 Q3 | 299 Thousand INR | -20.9% |
| 2021 FY | 629 Thousand INR | -36.07% |
| 2021 Q2 | 378 Thousand INR | 182.17% |
| 2020 Q4 | -796 Thousand INR | -133.39% |
| 2020 FY | 983.9 Thousand INR | 129.48% |
| 2020 Q1 | -1.61 Million INR | -144.16% |
| 2020 Q2 | 918 Thousand INR | 156.7% |
| 2020 Q3 | 2.38 Million INR | 159.69% |
| 2019 Q4 | 3.66 Million INR | 751.17% |
| 2019 FY | -3.33 Million INR | -1580.69% |
| 2019 Q3 | -563 Thousand INR | 70.78% |
| 2019 Q2 | -1.92 Million INR | -106.98% |
| 2019 Q1 | -931 Thousand INR | -119.96% |
| 2018 Q3 | -1.46 Million INR | -470.31% |
| 2018 Q4 | -423.26 Thousand INR | 71.01% |
| 2018 Q2 | -256 Thousand INR | -113.36% |
| 2018 FY | -198.55 Thousand INR | -103.3% |
| 2018 Q1 | 1.91 Million INR | 17.6% |
| 2017 FY | 6.02 Million INR | 299.06% |
| 2017 Q3 | 1.82 Million INR | 64.32% |
| 2017 Q4 | 1.62 Million INR | -10.67% |
| 2017 Q1 | 1.47 Million INR | -9.29% |
| 2017 Q2 | 1.11 Million INR | -24.59% |
| 2016 Q1 | -1.43 Million INR | -1052.65% |
| 2016 Q3 | -2 Million INR | -108.72% |
| 2016 Q2 | -963 Thousand INR | 33.03% |
| 2016 Q4 | 1.62 Million INR | 180.73% |
| 2016 FY | -3.02 Million INR | -397.9% |
| 2015 Q2 | -91 Thousand INR | 68.62% |
| 2015 Q4 | -124.75 Thousand INR | -27.3% |
| 2015 FY | -607.76 Thousand INR | -15.68% |
| 2015 Q1 | -290 Thousand INR | -96.8% |
| 2015 Q3 | -98 Thousand INR | -7.69% |
| 2014 Q1 | -135 Thousand INR | 56.78% |
| 2014 Q3 | -41 Thousand INR | 79.6% |
| 2014 Q2 | -201 Thousand INR | -48.89% |
| 2014 FY | -525.36 Thousand INR | -3.14% |
| 2014 Q4 | -147.36 Thousand INR | -259.42% |
| 2013 Q3 | -33 Thousand INR | -10.0% |
| 2013 Q2 | -30 Thousand INR | 77.44% |
| 2013 Q1 | -133 Thousand INR | -101.33% |
| 2013 Q4 | -312.34 Thousand INR | -846.5% |
| 2013 FY | -509.34 Thousand INR | 5.27% |
| 2012 FY | -537.68 Thousand INR | 0.0% |
| 2012 Q4 | 9.97 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 531.8 Thousand INR | -2689.018% |
| KIMIA BIOSCIENCES LIMITED | -37.75 Million INR | 139.283% |
| SHELTER PHARMA LIMITED | 98.67 Million INR | 84.968% |
| Vasundhara Rasayans Limited | 61.27 Million INR | 75.795% |
| Sunil Healthcare Limited | -19.98 Million INR | 174.231% |
| Chemo Pharma Laboratories Limited | 16.43 Million INR | 9.754% |
| MedPlus Health Services Limited | 1.31 Billion INR | 98.876% |
| Bharat Immunologicals & Biologicals Corporation Limited | -160.07 Million INR | 109.266% |
| Patidar Buildcon Limited | -1.83 Million INR | 907.843% |
| Roopa Industries Limited | 48.05 Million INR | 69.137% |
| Smruthi Organics Limited | - INR | -Infinity% |
| Trident Lifeline Limited | 72.21 Million INR | 79.46% |
| PANJON LTD. | - INR | -Infinity% |
| Pharmaids Pharmaceuticals Limited | -149.31 Million INR | 109.934% |
| Gujarat Terce Laboratories Limited | 8.99 Million INR | -64.983% |
| TIAAN CONSUMER LIMITED | -17.91 Million INR | 182.782% |
| Anuh Pharma Limited | 682.19 Million INR | 97.826% |
| Crestchem Limited | 27.25 Million INR | 45.582% |
| Emmessar Biotech & Nutrition Limited | -11.75 Million INR | 226.176% |
| Sandu Pharmaceuticals Limited | 17.12 Million INR | 13.39% |
| Tyche Industries Limited | 111.22 Million INR | 86.665% |
| Fredun Pharmaceuticals Limited | 364.25 Million INR | 95.928% |
| Trimurthi Limited | -6.14 Million INR | 341.444% |
| Shukra Pharmaceuticals Limited | 236.26 Million INR | 93.722% |
| Norris Medicines Limited | 11.15 Million INR | -32.937% |
| Zenlabs Ethica Limited | 89.27 Million INR | 83.387% |
| Vikram Thermo (India) Limited | 339.45 Million INR | 95.631% |
| ANG Lifesciences India Limited | 12.8 Million INR | -15.83% |
| Parmax Pharma Limited | 3.75 Million INR | -295.041% |
| Veerhealth Care Limited | 34.19 Million INR | 56.621% |
| Deccan Health Care Limited | 185.32 Million INR | 91.997% |
| SUDARSHAN PHARMA INDUSTRIES LI | 215.67 Million INR | 93.123% |
| Makers Laboratories Limited | -34.91 Million INR | 142.486% |
| Lactose (India) Limited | 137.78 Million INR | 89.235% |
| OXYGENTA PHARMACEUTICAL LIMITE | -123.57 Million INR | 112.003% |
| Zenith Healthcare Limited | 196 Thousand INR | -7467.347% |
| Sanjivani Paranteral Limited. | 64.47 Million INR | 76.994% |
| Bacil Pharma Limited | -1.89 Million INR | 882.964% |
| PRAVEG LIMITED | 185.06 Million INR | 91.986% |
| Denis Chem Lab Limited | 142.87 Million INR | 89.619% |
| Kwality Pharmaceuticals Limited | 500.7 Million INR | 97.038% |
| Jenburkt Pharmaceuticals Limited | 669.04 Million INR | 97.783% |
| Colinz Laboratories Limited | 14.64 Million INR | -1.291% |
| Godavari Drugs Limited | -67.67 Million INR | 121.918% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 3753.202% |
| Zenotech Laboratories Limited | 242.37 Million INR | 93.881% |
| Panchsheel Organics Limited | 288.28 Million INR | 94.855% |
| Shree Ganesh Remedies Limited | 572.48 Million INR | 97.409% |
| Phaarmasia Limited | - INR | -Infinity% |
| Sastasundar Ventures Limited | -229.64 Million INR | 106.459% |
| Medi-Caps Limited | -17.21 Million INR | 186.182% |
| DECIPHER LABS LIMITED | 53.74 Million INR | 72.4% |
| Gujarat Themis Biosyn Limited | 853.97 Million INR | 98.263% |
| Ambalal Sarabhai Enterprises Limited | 436.8 Million INR | 96.604% |
| Mercury Laboratories Limited | 62.14 Million INR | 76.134% |
| Gennex Laboratories Limited | 146.61 Million INR | 89.884% |
| BDH Industries Limited | 169.01 Million INR | 91.224% |
| Coral Laboratories Limited | 142.63 Million INR | 89.601% |
| Concord Drugs Limited | 24.87 Million INR | 40.367% |
| Bharat Parenterals Limited | 733.49 Million INR | 97.978% |
| Beryl Drugs Limited | 14.73 Million INR | -0.679% |
| Vista Pharmaceuticals Limited | -10.14 Million INR | 246.171% |
| Evoq Remedies Limited | 42.91 Million INR | 65.44% |
| Add-Shop E-Retail Limited | 77.57 Million INR | 80.879% |
| Transchem Limited | -17.43 Million INR | 185.051% |
| Ishita Drugs and Industries Limited | 7.96 Million INR | -86.145% |
| Parnax Lab Limited | 166.84 Million INR | 91.11% |
| Source Natural Foods and Herbal Supplements Limited | 34.15 Million INR | 56.574% |
| Kerala Ayurveda Limited | 48.04 Million INR | 69.13% |
| Cian Healthcare Limited | 53.96 Million INR | 72.518% |
| Trinity League India Limited | 1.17 Million INR | -1164.45% |
| Syschem (India) Limited | 504.91 Million INR | 97.062% |
| KOBO BIOTECH LIMITED | -2.48 Million INR | 698.065% |
| Natural Capsules Limited | 112.4 Million INR | 86.804% |
| Auro Laboratories Limited | 95.77 Million INR | 84.514% |